TABLE 1.
The antimicrobial susceptibilities of the donor strains, transconjugants, and recipient strains used in this studya
| Strains | MICs (mg/L) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| RIF | FUS | FFC | LZD | TZD | TET | GEN | VAL | LIN | ERY | |
| E. faecalis | ||||||||||
| Donor E006 | <1 | 2 | 128 | 16 | 4 | 128 | >128 | >128 | >128 | >128 |
| Recipient JH2-2 | >128 | >128 | 2 | 2 | 1 | 2 | 32 | >128 | 16 | <1 |
| Transconjugant E006×JH2-2-TC1 | >128 | >128 | 64 | 16 | 4 | <1 | >128 | >128 | >128 | >128 |
| E. faecium | ||||||||||
| Donor E843 | 16 | 2 | 128 | 4 | 1 | 128 | >128 | 32 | >128 | >128 |
| Recipient GE-1 | >128 | >128 | 1 | 1 | 0.5 | 64 | 8 | <1 | 16 | 2 |
| Transconjugant E843×GE-1-TC1 | >128 | 128 | 8 | 4 | 1 | 128 | >128 | 16 | >128 | >128 |
a
RIF, rifampicin; FUS, fusidic acid; FFC, florfenicol; LZD, linezolid; TZD, tedizolid; TET, tetracycline; GEN, gentamicin; VAL, valnemulin; LIN, lincomycin; ERY, erythromycin.